Mode
Text Size
Log in / Sign up

POCUS-assisted catheterization increases first-attempt success to 89.7% versus 72.5% in children under 36 months

POCUS-assisted catheterization increases first-attempt success to 89.7% versus 72.5% in children…
Photo by Elen Sher / Unsplash
Key Takeaway
Consider POCUS guidance for urethral catheterization in young children to improve first-attempt success.

This systematic review and meta-analysis examined the efficacy of real-time POCUS-assisted urethral catheterization compared to standard blind urethral catheterization in children aged ≤ 36 months within an emergency department setting. The analysis included a total sample size of 337 patients to assess procedural outcomes and workflow metrics.

The primary outcome measured was the first-attempt success rate. POCUS-assisted catheterization significantly increased first-attempt success compared to the conventional technique, with an absolute success rate of 89.7% versus 72.5%. The relative risk was 1.25 with a 95% CI of 1.08-1.45 and a p-value of 0.0022.

Secondary outcomes included the rate of dry taps, caregiver satisfaction, perceived patient discomfort, and overall workflow times. Ultrasound guidance significantly reduced the rate of dry taps, with an absolute rate of 3.6% versus 23.9%. The relative risk was 0.25 with a 95% CI of 0.13-0.47 and a p-value less than 0.0001. Adverse events, serious adverse events, discontinuations, and tolerability were not reported. The certainty of evidence for the primary outcome was rated as moderate. The authors support the integration of ultrasound guidance into routine pediatric emergency care.

Study Details

Study typeMeta analysis
Sample sizen = 337
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BACKGROUND: Urethral catheterization is the standard method for obtaining sterile urine in nontoilet-trained children, but the conventional blind technique frequently results in futile attempts ("dry taps") on empty bladders. Point-of-care ultrasound (POCUS) offers the clinical advantage of confirming adequate urine volume to prevent mucosal trauma and procedural distress. However, its routine implementation may be limited by operator training requirements and potential workflow delays while waiting for bladder filling. Therefore, this study aims to evaluate the efficacy of real-time POCUS-assisted versus standard blind urethral catheterization in pediatric patients. METHODS: We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) adhering to PRISMA guidelines (PROSPERO: CRD420251247483). We searched PubMed, Embase, and CENTRAL for trials comparing POCUS-guided versus standard catheterization in children aged ≤ 36 months. The primary outcome was the first-attempt success rate. The certainty of evidence was evaluated using the GRADE approach. RESULTS: Three trials comprising 337 participants were included. POCUS-assisted catheterization significantly increased first-attempt success compared to the conventional technique (89.7% vs. 72.5%; RR 1.25, 95% CI 1.08-1.45, p = 0.0022), yielding a Number Needed to Treat (NNT) of 6. Furthermore, ultrasound guidance significantly reduced the rate of "dry taps" (3.6% vs. 23.9%; RR 0.25, 95% CI 0.13-0.47, p < 0.0001), representing an NNT of 5 to prevent one futile attempt. The certainty of evidence for the primary outcome was rated as moderate. Secondary descriptive outcomes indicated higher caregiver satisfaction, lower perceived patient discomfort, and comparable overall workflow times despite required waiting periods for bladder filling. CONCLUSIONS: Real-time POCUS significantly improves first-attempt catheterization success and drastically reduces futile attempts in young children. Furthermore, it enhances caregiver satisfaction and minimizes patient distress without intrinsically delaying emergency department workflow. These highly actionable findings support the integration of ultrasound guidance into routine pediatric emergency care.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.